BAYER AG
๐ฉ๐ชGermany
- Country
- ๐ฉ๐ชGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function
- First Posted Date
- 2022-06-15
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 27
- Registration Number
- NCT05419635
- Locations
- ๐ฉ๐ช
CRS-Kiel, Kiel, Schleswig-Holstein, Germany
A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 600
- Registration Number
- NCT05407662
- Locations
- ๐บ๐ธ
Many Locations, Whippany, New Jersey, United States
A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- Bayer
- Registration Number
- NCT05406219
A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers
- First Posted Date
- 2022-05-27
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14
- Registration Number
- NCT05395858
- Locations
- ๐บ๐ธ
University of California, Davis, Sacramento, California, United States
๐บ๐ธTulane University, New Orleans, Louisiana, United States
๐บ๐ธRegents of the University of Minnesota, Minneapolis, Minnesota, United States
A Pharmacy-based Observational Study to Learn More About Iberogast Advance in the Real-world Setting
- First Posted Date
- 2022-05-25
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 184
- Registration Number
- NCT05389709
- Locations
- ๐ฉ๐ช
Many Locations, Multiple Locations, Many Locations, Germany
A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-05-19
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16
- Registration Number
- NCT05381142
- Locations
- ๐จ๐ณ
The First Affiliated Hospital of Guangzhou University of TCM, Guangzhou, Guangdong, China
An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 870
- Registration Number
- NCT05362149
- Locations
- ๐บ๐ธ
Bayer, Whippany, New Jersey, United States
A Study Called GUS to Understand How Much of the Contrast Agent Gadavist is Used and How Much is Wasted in Two Different Containers (Single-dose Vials and Imaging Bulk Packages ) in a Real-world Setting
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1602
- Registration Number
- NCT05350189
- Locations
- ๐บ๐ธ
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
๐บ๐ธWestern Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 18
- Registration Number
- NCT05351892
- Locations
- ๐บ๐ธ
Clinical Pharmacology of Miami, LLC, Miami, Florida, United States
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 4500
- Registration Number
- NCT05348733
- Locations
- ๐บ๐ธ
Nephrology Consultants LLC, Huntsville, Alabama, United States
๐บ๐ธAKDHC Medical Research Servies LLC, Phoenix, Arizona, United States
๐บ๐ธHarrisburg Family Medical Center, Harrisburg, Arkansas, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath